Study identifies new therapeutic target in Non-Hodgkin’s Lymphoma

Posted by on October 3, 2016 1:32 pm
Categories: health

Researchers have discovered that an enzyme called uracil-DNA glycosylase (UNG) protects the ends of B cell chromosomes to facilitate the proliferation of these antibody-producing cells in response to infection. The study also suggests that targeting this enzyme may help treat certain types of non-Hodgkin’s lymphoma.

Leave a Reply

Your email address will not be published. Required fields are marked *